Genzyme Corporation (GENZ) Recognizes International Rare Disease Day With Global Awareness Programs And Launch Of Fourth Annual Patient Advocacy Leadership (PAL) Awards
2/28/2014 9:14:59 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), today announced its support of International Rare Disease Day with a series of initiatives meant to call attention to rare diseases as an important public health issue and to improve rare disease education, research, and treatment. Observed annually on the last day of February, Rare Disease Day is an international awareness campaign organized by the patient organization EURORDIS and supported by hundreds of other patient organizations around the world.
Help employers find you! Check out all the jobs and post your resume.
comments powered by